Lung cancer immunotherapy duration study halted early

NCT ID NCT04880382

Terminated Knowledge-focused Sponsor: Institut Bergonié Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated Jun 12, 2026 · Updated 33 times

Summary

This study looked at how long to continue immunotherapy in people with advanced non-small cell lung cancer who had already responded well to treatment for 6 to 12 months. The goal was to see if stopping or continuing treatment made a difference in keeping the cancer from growing. Only 8 people took part before the study was stopped early, so the results are very limited.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON SMALL CELL LUNG CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Centre Hospitalier de la Côte Basque

Bayonne, 64109, France
Clinique Marzet

Pau, France
Clinique Tivoli Ducos

Bordeaux, 33000, France
Institut Bergonie

Bordeaux, 33076, France
Polyclinique Bordeaux Nord Aquitaine

Bordeaux, 33077, France

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NON SMALL CELL LUNG CANCER NON-SMALL CELL LUNG CANCER